Single ascending dose study of the safety, tolerability, and pharmacokinetics of FXR-450 administered orally to healthy subjects
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2008
At a glance
- Drugs Turofexorate isopropyl (Primary)
- Indications Lipid metabolism disorders
- Focus Adverse reactions
- 12 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 15 Feb 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
- 27 Dec 2007 Status change from initiated to recruiting.